European Medicine Agency’s CHMP Qualifies First AI Tool For Use In Clinical Trials
PathAI’s Tool Can Increase Reproducibility And Repeatability
With the support of AIM-MASH AI Assist only one pathologist is needed to reliably make a histology assessment of inflammatory liver disease to decide whether patients should be included in MASH clinical trials.
